Patent ID: 9333241
Filing Date: 2016-05-10
CPC Classification: A61K,A61P

Claim Text:
1. A method for inducing lipolysis in a human subject who has metabolic syndrome, comprising: administering to the subject a composition that comprises (a) a thyroid-stimulating hormone receptor (TSHR) agonist preparation selected from (i) a recombinant human thyroid-stimulating hormone (TSH) preparation and (ii) a recombinant human corticotroph-derived glycoprotein hormone (CGH) preparation; and (b) a pharmaceutically acceptable carrier, wherein said TSHR agonist preparation is at least 90% desialylated, wherein the TSHR agonist preparation is administered in an amount effective to induce lipolysis in a plurality of adipocytes without inducing thyrotoxicosis in the subject.